Total Payments
$3,239
2024 Payments
$658.67
Companies
14
Transactions
213
Medicare Patients
1,134
Medicare Billing
$189,768
Payment Breakdown by Category
Food & Beverage$3,165 (97.7%)
Education$74.18 (2.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,165 | 211 | 97.7% |
| Education | $74.18 | 2 | 2.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sunovion Pharmaceuticals Inc. | $816.01 | 48 | $0 (2022) |
| ABBVIE INC. | $445.19 | 48 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $410.89 | 24 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $388.15 | 27 | $0 (2024) |
| Alkermes, Inc. | $387.26 | 23 | $0 (2022) |
| Otsuka America Pharmaceutical, Inc. | $197.85 | 12 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $146.93 | 8 | $0 (2024) |
| ITI, Inc. | $85.58 | 4 | $0 (2022) |
| Supernus Pharmaceuticals, Inc. | $85.52 | 5 | $0 (2023) |
| Tris Pharma Inc | $80.17 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $658.67 | 41 | Otsuka America Pharmaceutical, Inc. ($183.17) |
| 2023 | $664.05 | 46 | Teva Pharmaceuticals USA, Inc. ($239.05) |
| 2022 | $942.92 | 65 | Alkermes, Inc. ($271.32) |
| 2021 | $973.57 | 61 | Sunovion Pharmaceuticals Inc. ($573.77) |
All Payment Transactions
213 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $17.40 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/12/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $7.32 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/04/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $5.68 | General |
| Category: Neurology | ||||||
| 11/18/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $31.54 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/18/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $11.61 | General |
| Category: Psychiatry/Psychology | ||||||
| 10/29/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $23.14 | General |
| Category: Psychiatry/Psychology | ||||||
| 10/10/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: PSYCHIATRY | ||||||
| 10/09/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $6.69 | General |
| Category: Neurology | ||||||
| 10/03/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Education | In-kind items and services | $27.27 | General |
| Category: Psychiatry/Psychology | ||||||
| 10/03/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $26.59 | General |
| Category: Psychiatry/Psychology | ||||||
| 10/03/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $2.06 | General |
| Category: Psychiatry/Psychology | ||||||
| 09/18/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $8.53 | General |
| Category: Neurology | ||||||
| 09/03/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: PSYCHIATRY | ||||||
| 06/28/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: ADHD | ||||||
| 06/12/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: Psychology/Psychiatric | ||||||
| 06/10/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $10.29 | General |
| Category: PSYCHIATRY | ||||||
| 06/06/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $24.20 | General |
| Category: Neuropsychiatry | ||||||
| 05/25/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $24.68 | General |
| Category: ADHD | ||||||
| 05/22/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $9.65 | General |
| Category: Neurology | ||||||
| 05/16/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: ADHD | ||||||
| 05/15/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $24.68 | General |
| Category: Neuroscience | ||||||
| 05/09/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), REXULTI | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: PSYCHIATRY | ||||||
| 05/01/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $8.98 | General |
| Category: Central Nervous System | ||||||
| 04/22/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: PSYCHIATRY | ||||||
| 04/17/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $8.61 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 274 | 760 | $120,515 | $45,437 |
| 2022 | 4 | 267 | 861 | $126,575 | $47,203 |
| 2021 | 6 | 323 | 920 | $110,510 | $52,145 |
| 2020 | 6 | 270 | 940 | $114,160 | $44,982 |
Total Patients
1,134
Total Services
3,481
Medicare Billing
$189,768
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 127 | 424 | $63,600 | $21,657 | 34.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 93 | 188 | $31,960 | $14,571 | 45.6% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2023 | 12 | 87 | $15,225 | $4,978 | 32.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 15 | 15 | $3,750 | $2,181 | 58.2% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 27 | 46 | $5,980 | $2,050 | 34.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 136 | 495 | $68,050 | $23,768 | 34.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 100 | 223 | $35,310 | $16,033 | 45.4% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2022 | 12 | 104 | $18,200 | $5,720 | 31.4% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 19 | 39 | $5,015 | $1,682 | 33.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 151 | 568 | $62,480 | $29,875 | 47.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 84 | 151 | $19,630 | $11,806 | 60.1% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2021 | 13 | 99 | $17,325 | $5,691 | 32.8% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 19 | 19 | $3,800 | $2,299 | 60.5% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 35 | 52 | $6,500 | $2,190 | 33.7% |
| 90785 | Interactive complexity | Office | 2021 | 21 | 31 | $775.00 | $284.76 | 36.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 145 | 615 | $67,650 | $26,151 | 38.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 56 | 127 | $16,510 | $7,987 | 48.4% |
| 90836 | Psychotherapy, 45 minutes | Office | 2020 | 13 | 110 | $19,250 | $6,460 | 33.6% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 30 | 30 | $6,000 | $2,503 | 41.7% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 15 | 33 | $4,125 | $1,619 | 39.2% |
| 90785 | Interactive complexity | Office | 2020 | 11 | 25 | $625.00 | $262.08 | 41.9% |
About Jennifer Brown, PHM-CNS/ NP
Jennifer Brown, PHM-CNS/ NP is a Psychiatric/Mental Health healthcare provider based in Virginia Beach, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/30/2005. The National Provider Identifier (NPI) number assigned to this provider is 1063405686.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jennifer Brown, PHM-CNS/ NP has received a total of $3,239 in payments from pharmaceutical and medical device companies, with $658.67 received in 2024. These payments were reported across 213 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($3,165).
As a Medicare-enrolled provider, Brown has provided services to 1,134 Medicare beneficiaries, totaling 3,481 services with total Medicare billing of $189,768. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatric/Mental Health
- Other Specialties Psychiatric/Mental Health
- Location Virginia Beach, VA
- Active Since 08/30/2005
- Last Updated 12/27/2016
- Taxonomy Code 364SP0808X
- Entity Type Individual
- NPI Number 1063405686
Products in Payments
- LATUDA (Drug) $816.01
- VRAYLAR (Drug) $409.40
- SPRAVATO (Drug) $378.97
- ARISTADA (Drug) $291.05
- UZEDY (Drug) $249.26
- COBENFY (Drug) $146.93
- CAPLYTA (Drug) $107.96
- LYBALVI (Drug) $96.21
- QELBREE (Drug) $85.52
- ABILIFY MAINTENA (Drug) $83.36
- REXULTI (Drug) $80.82
- Dyanavel XR (Drug) $80.17
- INGREZZA (Drug) $79.60
- AZSTARYS (Drug) $41.44
- Azstarys (Drug) $37.35
- UBRELVY (Drug) $35.79
- ABILIFY ASIMTUFII (Drug) $33.67
- INVEGA SUSTENNA (Drug) $31.92
- Austedo XR (Drug) $22.28
- Auvelity (Drug) $14.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatric/Mental Health Doctors in Virginia Beach
Genise Binns
Psychiatric/Mental Health — Payments: $10,066
Psychiatric/Mental Health $10,066
Mrs. Nakeshia Mouzon, Fnp, Pmhnp, FNP, PMHNP
Psychiatric/Mental Health — Payments: $6,575
Psychiatric/Mental Health $6,575
Mary Crutchfield, Pmhnp, Fnp, PMHNP, FNP
Psychiatric/Mental Health — Payments: $6,091
Psychiatric/Mental Health $6,091
Mrs. Arnella Edwards
Psychiatric/Mental Health — Payments: $5,663
Psychiatric/Mental Health $5,663
Jamie Deputy, Msn, Aprn, Pmhnp-Bc, MSN, APRN, PMHNP-BC
Psychiatric/Mental Health — Payments: $4,582
Psychiatric/Mental Health $4,582
Brittany Smith, Pmhnp, PMHNP
Psychiatric/Mental Health — Payments: $4,301
Psychiatric/Mental Health $4,301